Sanofi Adr (SNY)

Jan 20, 2025

Pain Management Therapeutics Market Is Expected To Reach Revenue Of USD 120.7 Bn By 2033, At 3.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.

Jan 20, 2025

Jan 17, 2025

7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - GlobeNewswire Inc.

Jan 17, 2025

Dec 23, 2024

Gsk Plc ADR (GSK-N) QuotePress Release - The Globe and Mail

Dec 23, 2024

Dec 19, 2024

Communiqué de presse - GlobeNewswire Inc.

Dec 19, 2024

Dec 18, 2024

Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily

Dec 18, 2024

Dec 18, 2024

10 Best Blue-Chip Stocks to Buy for the Long Term - Morningstar

Dec 18, 2024

Dec 17, 2024

Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug - Investor's Business Daily

Dec 17, 2024

Dec 17, 2024

What Did We Find About Insider Trading At Sanofi ADR (NASDAQ: SNY)? - Stocks Register

Dec 17, 2024

Dec 16, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Dec 16, 2024

Dec 12, 2024

Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - MSN

Dec 12, 2024

Dec 10, 2024

Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily

Dec 10, 2024

Dec 06, 2024

Top-3 International Stocks Beating Their U.S. Peers for Dividend Earnings - TheStreet

Dec 06, 2024

Dec 04, 2024

Teva Pharmaceutical ADR Gets Relative Strength Rating Upgrade - Investor's Business Daily

Dec 04, 2024

Dec 03, 2024

Novo Nordisk and AstraZeneca top 2025 drug picks for US investment bankread why - Proactive Investors USA

Dec 03, 2024

Nov 30, 2024

Why Sanofi (SNY) Is One of the Best ADR Stocks to Invest in? - Insider Monkey

Nov 30, 2024

Nov 29, 2024

12 Best ADR Stocks To Invest In According to Analysts - Insider Monkey

Nov 29, 2024

Nov 06, 2024

T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - GlobeNewswire Inc.

Nov 06, 2024

Nov 06, 2024

How Robert F. Kennedy Jr. Will Bring Major Uncertainties to U.S. Healthcare - Barron's

Nov 06, 2024

Oct 30, 2024

Sanofi Cancels Consumer Healthcare Business Spin-Off - Forbes

Oct 30, 2024

Oct 30, 2024

Here’s Why Mastercard Incorporated (NYSE: MA) Is An Attractive Investment Right Now - Stocks Register

Oct 30, 2024